Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.
| Current Price | ₹21.49 |
|---|---|
| Market Cap | ₹11 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | 25.6 |
| Return on Equity | 4.38% |
| 52-Week Range | ₹15.92 – ₹30.00 |
| Beta (1Y) | 0.72 |
Beryl Drugs Ltd. is trading at ₹21.49, with a market capitalisation of ₹11 Cr.
Beryl Drugs Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Beryl Drugs Ltd. has a P/E of 25.6 and a return on equity of 4.38%.